GLAXOSMITHKLINE
GLAXOSMITHKLINE
Share · GB0009252882 · 940561 (XLON)
Overview Financial Indicators
15,09 GBP
-3,14 % -0,49 GBP
Closing Price XLON 10.06.2025: 1.508,50 GBX
London (XLON) · Current prices and charts at MoneyPeak
10.06.2025 15:14

Current Prices from GLAXOSMITHKLINE

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
GSK.L
GBX
10.06.2025 15:14
1.508,50 GBX
1.508,00 GBX
+0,03 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,97 % 9,80 % -3,03 % 9,39 % -6,59 % -7,57 %

Company Profile for GLAXOSMITHKLINE Share

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Invested Funds

The following funds have invested in: GLAXOSMITHKLINE invested:

Fund
iShares STOXX Europe Select Dividend 30 UCITS ETF (DE)
Vol. in million
26.710,97
Percentage (%)
6,20 %
Fund
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in million
2.672,42
Percentage (%)
6,12 %
Fund
iShares MSCI Europe Quality Dividend UCITS ETF
Vol. in million
3.588,40
Percentage (%)
4,21 %
Fund
iShares MSCI UK UCITS ETF GBP (Acc)
Vol. in million
4.967,85
Percentage (%)
4,03 %
Fund
iShares Core FTSE 100 UCITS ETF GBP (Acc)
Vol. in million
63.663,50
Percentage (%)
3,69 %

Company Data

Name GLAXOSMITHKLINE
Company GSK plc
Website https://www.gsk.com
Primary Exchange XLON London
WKN 940561
ISIN GB0009252882
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Ms. Emma Natasha Walmsley
Market Capitalization 54 Mrd.
Country United Kingdom
Currency GBP
Employees 68,6 T
Address 980 Great West Road, TW8 9GS Brentford
IPO Date 1988-07-01
Dividends from 'GLAXOSMITHKLINE'
Ex-Date Dividend per Share
15.05.2025 16,00 GBX
20.02.2025 16,00 GBX
14.11.2024 15,00 GBX
15.08.2024 15,00 GBX
16.05.2024 15,00 GBX
22.02.2024 16,00 GBX
16.11.2023 14,00 GBX
17.08.2023 14,00 GBX
18.05.2023 14,00 GBX
23.02.2023 13,75 GBX

Stock Splits

Date Split
19.07.2022 4:5
28.10.1991 2:1
24.11.1989 2:1

Ticker Symbols

Name Symbol
London GSK.L

More Shares

Investors who GLAXOSMITHKLINE hold also have the following shares in their portfolio:
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
AT & T INC
AT & T INC Share
BITCOIN
BITCOIN Crypto
COCA-COLA CO
COCA-COLA CO Share
GENL ELECTR 20/50
GENL ELECTR 20/50 Bond
INVESTOR B (FRIA)
INVESTOR B (FRIA) Share
LEXSTON LIFE SCIENCES
LEXSTON LIFE SCIENCES Share
MICROSOFT CORP
MICROSOFT CORP Share
MÜNCHENER RÜCK AG
MÜNCHENER RÜCK AG Share
Novo Nordisk (alt)
Novo Nordisk (alt) Share
RIO TINTO
RIO TINTO Share
TENCENT . LTD
TENCENT . LTD Share
UNILEVER PLC
UNILEVER PLC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025